STUNNING HEALTH BREAKTHROUGHS, INC. – Trademark Portfolio
Entity Type: 03
STUNNING HEALTH BREAKTHROUGHS, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include EXPERT REMEDIES, BRILLIANT REMEDIES, SPECTRUM DISCOVERY, ADVANCED KNEE DISCOVERY, and ADVANCED GLUCOSE DISCOVERY. The owner is based in RIVERHEAD, NY.
865 OLD COUNTRY ROAD, SUITE #321
RIVERHEAD, NY 11901
Showing of trademarks Trademarks
Trademark Classifications
STUNNING HEALTH BREAKTHROUGHS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does STUNNING HEALTH BREAKTHROUGHS, INC. have?
STUNNING HEALTH BREAKTHROUGHS, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 abandoned, 1 cancelled.
What trademark classes does STUNNING HEALTH BREAKTHROUGHS, INC. file in?
STUNNING HEALTH BREAKTHROUGHS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are STUNNING HEALTH BREAKTHROUGHS, INC.'s most well-known trademarks?
STUNNING HEALTH BREAKTHROUGHS, INC.'s registered trademark portfolio includes well-known marks such as EXPERT REMEDIES, BRILLIANT REMEDIES, SPECTRUM DISCOVERY, ADVANCED KNEE DISCOVERY, and ADVANCED GLUCOSE DISCOVERY. These are among 5 currently registered trademarks in the portfolio.
What is STUNNING HEALTH BREAKTHROUGHS, INC.'s trademark registration success rate?
STUNNING HEALTH BREAKTHROUGHS, INC. has a 50% trademark registration rate, with 5 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.